eCQM Data Element Performance/Reporting Period 2019 Value Set Description from VSAC Clinical Focus: This value set contains concepts that represent gender identity restricted to only male and female used in administrative situations requiring a restriction to these two categories. Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Sex. Inclusion Criteria: Includes relevant concepts associated with gender concepts for male and female only. Exclusion Criteria: Excludes any gender identity that is not male or female. Constrained to codes in the Patient Characteristic Sex: ONC Administrative Sex value set (2.16.840.1.113762.1.4.1) QDM Datatype and Definition (QDM Version 5.3) Patient Characteristic Sex Data elements that meet criteria using this datatype should document that the patient's sex matches the QDM category and its corresponding value set. Timing: Birth (administrative) sex does not have a specific timing. eCQMs using this data element: CMS130v7 - Colorectal Cancer Screening CMS122v7 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%) CMS177v7 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment CMS160v7 - Depression Utilization of the PHQ-9 Tool CMS165v7 - Controlling High Blood Pressure CMS159v7 - Depression Remission at Twelve Months CMS145v7 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) CMS155v7 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents CMS137v7 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment CMS074v8 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists CMS129v8 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients CMS144v7 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) CMS056v7 - Functional Status Assessment for Total Hip Replacement CMS143v7 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation CMS132v7 - Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures CMS002v8 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan CMS052v7 - HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis CMS156v7 - Use of High-Risk Medications in the Elderly CMS153v7 - Chlamydia Screening for Women CMS124v7 - Cervical Cancer Screening CMS138v7 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS128v7 - Anti-depressant Medication Management CMS161v7 - Adult Major Depressive Disorder (MDD): Suicide Risk Assessment CMS136v8 - Follow-Up Care for Children Prescribed ADHD Medication (ADD) CMS347v2 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS149v7 - Dementia: Cognitive Assessment CMS134v7 - Diabetes: Medical Attention for Nephropathy CMS135v7 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) CMS157v7 - Oncology: Medical and Radiation - Pain Intensity Quantified CMS050v7 - Closing the Referral Loop: Receipt of Specialist Report CMS090v8 - Functional Status Assessments for Congestive Heart Failure CMS066v7 - Functional Status Assessment for Total Knee Replacement CMS249v1 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture CMS349v1 - HIV Screening CMS131v7 - Diabetes: Eye Exam CMS082v6 - Maternal Depression Screening CMS117v7 - Childhood Immunization Status CMS142v7 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care CMS068v8 - Documentation of Current Medications in the Medical Record CMS645v2 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy CMS133v7 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery CMS147v8 - Preventive Care and Screening: Influenza Immunization CMS154v7 - Appropriate Treatment for Children with Upper Respiratory Infection (URI) CMS146v7 - Appropriate Testing for Children with Pharyngitis CMS125v7 - Breast Cancer Screening CMS069v7 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan CMS022v7 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented CMS075v7 - Children Who Have Dental Decay or Cavities CMS127v7 - Pneumococcal Vaccination Status for Older Adults CMS139v7 - Falls: Screening for Future Fall Risk CMS111v7 - Median Admit Decision Time to ED Departure Time for Admitted Patients CMS009v7 - Exclusive Breast Milk Feeding CMS072v7 - Antithrombotic Therapy By End of Hospital Day 2 CMS055v7 - Median Time from ED Arrival to ED Departure for Admitted ED Patients CMS104v7 - Discharged on Antithrombotic Therapy CMS108v7 - Venous Thromboembolism Prophylaxis CMS190v7 - Intensive Care Unit Venous Thromboembolism Prophylaxis CMS031v7 - Hearing Screening Prior To Hospital Discharge CMS032v8 - Median Time from ED Arrival to ED Departure for Discharged ED Patients CMS102v7 - Assessed for Rehabilitation CMS071v8 - Anticoagulation Therapy for Atrial Fibrillation/Flutter CMS026v6 - Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver CMS107v7 - Stroke Education CMS105v7 - Discharged on Statin Medication CMS113v7 - Elective Delivery CMS053v7 - Primary PCI Received Within 90 Minutes of Hospital Arrival
CMS145v7 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS155v7 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS074v8 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS129v8 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS132v7 - Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS135v7 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS249v1 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS645v2 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy